Expert Review of Clinical Immunology
Volume 15, 2019 - Issue 5
Review
Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018
Karen M. MacDonaldDivision of Research, Matrix45, Tucson, AZ, USA
https://orcid.org/0000-0002-4568-9783View further author information
https://orcid.org/0000-0002-4568-9783View further author information, Abhishek KavatiHealth Economics & Outcomes Research, Novartis, East Hanover, NJ, USAhttps://orcid.org/0000-0001-8890-1134View further author information
https://orcid.org/0000-0001-8890-1134View further author information, Benjamin OrtizClinical Development & Medical Affairs, Novartis, East Hanover, NJ, USAhttps://orcid.org/0000-0001-6950-5582View further author information
https://orcid.org/0000-0001-6950-5582View further author information, Abdulaziz AlhossanCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabiahttps://orcid.org/0000-0001-5849-6756View further author information
https://orcid.org/0000-0001-5849-6756View further author information, Christopher S. LeeDivision of Research, Matrix45, Tucson, AZ, USA;Boston College, Connell School of Nursing, Boston, MA, USAhttps://orcid.org/0000-0002-2510-4071View further author information
https://orcid.org/0000-0002-2510-4071View further author information & Ivo AbrahamDivision of Research, Matrix45, Tucson, AZ, USA;Center for Health Outcomes and Pharmacoeconomic Research, University of Arizona, Tucson, AZ, USA;Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA;Department of Family and Community Medicine, College of Medicine – Tucson, University of Arizona, Tucson, AZ, USACorrespondence[email protected]
https://orcid.org/0000-0003-0490-4421View further author information
https://orcid.org/0000-0003-0490-4421View further author information